Big Data and the Collective Turn in Biomedicine. How Should We Analyze Post-genomic Practices? by Alberto Cambrosio, Pascale Bourret, Vololona Rabeharisoa, Michel Callon

Get full text

Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for M... by Robert Barouki, Joël Ankri, Patrick Maison, Christiane Druml, Valérie Sautou, Eric Bellissant, Laëtitia Belgodère, Dominique Pougheon Bertrand, Marie Christine Jaulent, Vololona Rabeharisoa, Walter Janssens, Victoria Rollason, Janine Barbot, Jean Paul Vernant, Wahiba Oualikene Gonin, Henri Bastos, Éric Ezan, Didier Houssin, Maria Emilia Monteiro, Dominique Pougheon Bertrand, Marie-Christine Jaulent, Jean-Paul Vernant

Get full text

Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines... by Wahiba Oualikene-Gonin, Valérie Sautou, Eric Ezan, Henri Bastos, Eric Bellissant, Laëtitia Belgodère, Patrick Maison, Patrick Maison, Patrick Maison, Joël Ankri, The Scientific Advisory Board of the ANSM, Joël Ankri, Janine Barbot, Robert Barouki, Henri Bastos, Éric Bellissant, Christiane Druml, Éric Ezan, Didier Houssin, Walter Janssens, Marie-Christine Jaulent, Maria Emilia Monteiro, Dominique Pougheon, Vololona Rabeharisoa, Victoria Rollason, Valérie Sautou, Jean-Paul Vernant

Get full text